
GC19146
Etrasimod
Also known as 2-[(3R)-7-[[4-cyclopentyl-3-(trifluoromethyl)phenyl]methoxy]-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]acetic acid
Etrasimod (APD334) is a potent, selective and orally available antagonist of the sphingosine-1-phosphate-1 (S1P1) receptor with an IC50 value of 1·88 nM in CHO cells
ChemicalCAS1206123-37-6MW457.48FormulaC26H26F3NO3
- CAS number
- 1206123-37-6
- Molecular weight
- 457.48
- Formula
- C26H26F3NO3
- Solubility
- DMSO : ≥ 28 mg/mL (61·20 mM)
- InChIKey
- MVGWUTBTXDYMND-QGZVFWFLSA-N
- Catalogue number
- GC19146
- Brand
- GLPBIO
Computed properties PubChem CID 44623998 · XLogP 6.4 · TPSA 62.3 Ų · H-bond donors 2
- XLogP
- 6.4
- TPSA
- 62.3 Ų
- H-bond donors
- 2
- H-bond acceptors
- 6
- Rotatable bonds
- 6
- Heavy atoms
- 33
SMILES C1CCC(C1)C2=C(C=C(C=C2)COC3=CC4=C(C=C3)NC5=C4CC[C@@H]5CC(=O)O)C(F)(F)F
Computed descriptors from PubChem (CID 44623998), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il